[Short-term curative effect of cultured Cordyceps sinensis (Berk.) Sacc. Mycelia in chronic hepatitis B].
33 cases of chronic hepatitis B. patients treated with cultured Cordyceps sinensis mycelia have shown that the drug improves the liver function, promotes negative transfer HBsAg, and markedly helps to raise plasma albumin, resist high gamma globulin and to adjust body immunocompetence. It is therefore suggested that cultured Cordyceps sinensis mycelia may be used as a medicine for chronic hepatitis B. patients in adjusting protein metabolism and correcting inversion of albumin and globulin.
Zhou
L
L
Shanxi Liver Diseases Research Co-operation Group.
Yang
W
W
Xu
Y
Y
Zhu
Q
Q
Ma
Z
Z
Zhu
T
T
Ge
X
X
Gao
J
J
D000418:Albumins / Q000378:metabolism; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy*; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D006999:Hypocreales; D008297:Male; D005719:gamma-Globulins / Q000378:metabolism
D000418:Albumins; D004365:Drugs, Chinese Herbal; D006514:Hepatitis B Surface Antigens; D005719:gamma-Globulins